title: Telomere dysfunction suppresses multiple endocrine neoplasia in mice.
abstract: Multiple endocrine neoplasia (MEN) syndrome is typified by the occurrence of tumors in two or more hormonal tissues. Whereas the genetics of MEN syndrome is relatively well understood, the tumorigenic mechanisms for these cancers remain relatively obscure. The Cdk4 (R24C) mouse model develops highly penetrant pituitary tumors and endocrine pancreas adenomas, and, as such, this model is appropriate to gain insight into mechanisms underlying MEN. Using this model, here we provide evidence supporting an important role for telomerase in the pathogenesis of MEN. We observed increased aneuploidy in Cdk4 (R/R) fibroblasts along with significantly elevated telomerase activity and telomere length in Cdk4 (R/R) islets and embryonic fibroblasts. To better understand the role of telomerase, we generated Cdk4 (R24C) mice with inactivation of the mTERC locus, which codes for the essential RNA component of the enzyme telomerase (mTERC (-/-) Cdk4 (R/R) mice). Embryonic fibroblasts and islets derived from mTERC (-/-) Cdk4 (R/R) mice exhibit reduced telomere length and proliferative capacity. Further, mTERC (-/-) Cdk4 (R/R) fibroblasts display reduced transformation potential. Importantly, mTERC (-/-) Cdk4 (R/R) mice display significantly reduced spontaneous tumorigenesis. Strikingly, we observed dramatic suppression of pituitary tumors and endocrine pancreas adenomas in mTERC (-/-) Cdk4 (R/R) mice. Telomere dysfunction suppressed tumor initiation and increased latency of tumor development while not affecting the progression of established tumors. In summary, these results are suggestive of an important role for telomerase in tumor development in the Cdk4 (R24C) mouse model, specifically in the genesis of tumors in the pituitary and the endocrine pancreas.
authors.affiliation: Diabetes, Endocrinology & Obesity Branch, National Institute of Diabetes & Digestive & Kidney Diseases, Bethesda, MD.
authors.forename: Ji-Hyeon
authors.initials: JH
authors.lastname: Lee
authors.affiliation: Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD.
authors.forename: Miriam
authors.initials: M
authors.lastname: Anver
authors.affiliation: Dana-Farber Cancer Institute, Boston, MA ; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX.
authors.forename: Maria
authors.initials: M
authors.lastname: Kost-Alimova
authors.affiliation: Dana-Farber Cancer Institute, Boston, MA ; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX.
authors.forename: Alexei
authors.initials: A
authors.lastname: Protopopov
authors.affiliation: Dana-Farber Cancer Institute, Boston, MA ; Department of Cell Biology, University of Texas MD Anderson Cancer Center, Houston, TX.
authors.forename: Ronald A
authors.initials: RA
authors.lastname: DePinho
authors.affiliation: Diabetes, Endocrinology & Obesity Branch, National Institute of Diabetes & Digestive & Kidney Diseases, Bethesda, MD.
authors.forename: Sushil G
authors.initials: SG
authors.lastname: Rane
keywords: Endocrine Neoplasia; Islets; Pancreas; Pituitary; Telomerase